DTIC and actinomycin D with and without C. parvum immunotherapy in advanced malignant melanoma.
D000328:Adult; D000368:Aged; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D003606:Dacarbazine / Q000627:therapeutic use*; D003609:Dactinomycin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D011425:Propionibacterium acnes / Q000276:immunology*; D012878:Skin Neoplasms / Q000628:therapy*
D001428:Bacterial Vaccines; D003609:Dactinomycin; D003606:Dacarbazine